<object id="q8oyw"></object>
<sup id="q8oyw"><option id="q8oyw"></option></sup><object id="q8oyw"><tr id="q8oyw"></tr></object>
<center id="q8oyw"><center id="q8oyw"></center></center>
<object id="q8oyw"></object>
<acronym id="q8oyw"><div id="q8oyw"></div></acronym>
<object id="q8oyw"></object>
<acronym id="q8oyw"><wbr id="q8oyw"></wbr></acronym>
<object id="q8oyw"></object>
咨詢(xún)熱線

15000266580

當(dāng)前位置:首頁(yè) >產(chǎn)品中心>細(xì)胞庫(kù)>人腫瘤細(xì)胞、癌細(xì)胞>HTB-30SKBR-3 人乳腺癌細(xì)胞

SKBR-3 人乳腺癌細(xì)胞

簡(jiǎn)要描述:HTB-30 SKBR-3 人乳腺癌細(xì)胞,ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞|貼壁細(xì)胞|懸浮細(xì)胞;細(xì)胞庫(kù)管理規(guī)范,提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和*培養(yǎng)條件!

  • 產(chǎn)品型號(hào):HTB-30
  • 廠商性質(zhì):生產(chǎn)廠家
  • 更新時(shí)間:2024-11-15
  • 訪  問(wèn)  量:1589

產(chǎn)品分類(lèi)

Product Category

相關(guān)文章

Related Articles

詳細(xì)介紹

HTB-30 SKBR-3 人乳腺癌細(xì)胞

ATCC® Number:HTB-30™    Price:$272.00
Designations:SK-BR-3

Depositors: G Trempe, LJ Old

Biosafety Level:1

Shipped:frozen

Medium & Serum:See Propagation

Growth Properties:adherent

Organism:Homo sapiens (human)

Morphology:epithelial

Source:Organ: mammary gland; breast

Disease: adenocarcinoma

Derived from metastatic site: pleural effusion



Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
HTB-30 SKBR-3 人乳腺癌細(xì)胞

Restrictions:The cells are distributed for research purposes only. The Memorial Sloan-Kettering Cancer Center releases the line subject to the following: 1.) The cells or their products must not be distributed to third parties. Commercial interests are the exclusive property of Memorial Sloan-Kettering Cancer Center. 2.) Any proposed commercial use of these cells must first be negotiated with The Director, Office of Industrial Affairs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; phone (212) 639-6181; (212) 717-3439.

Isolation:Isolation date: 1970

Applications:transfection host (Nucleofection technology from Lonza

Roche FuGENE® Transfection Reagents)



Tumorigenic:Yes

Antigen Expression:Blood Type A; Rh+; HLA A11, Bw22(+/-), B40, B18

DNA Profile (STR):Amelogenin: X

CSF1PO: 12

D13S317: 11,12

D16S539: 9

D5S818: 9,12

D7S820: 9,12

THO1: 8,9

TPOX: 8,11

vWA: 17



Cytogenetic Analysis:This is a hypertriploid human cell line with the modal chromosome number of 84, occurring in 34% of cells. Cells having 80 chromosomes also occurred at a high rate (28%); the higher ploidy cells occurred at 7.3%. This cell line has a very complex chromosome composition. Thirty-five to 40% of chromosomes in a cell complement with a modal chromosome number of 84 consisted of structurally altered marker chromosomes. Several markers are longer than chromosome N1. The origins of most of these markers, however, are not clear. Some markers may have at least three individual chromosome segments. The markers [i.e., ?der(1)t(1;21) (p13;q21) [or ?t(1q21q)], ?del(2) (q13), and t(7pter--cen--?), present in some cells only] were the only ones in which portions of chromosome segments could be identified. Most cells had about three normal X chromosomes and five or more N7. The structurally normal N1, N14 and N17 were generally absent.

Isoenzymes:AK-1, 1-2

ES-D, 1

G6PD, B

GLO-I, 2

PGM1, 1-2

PGM3, 1



Age:43 years

Gender:female

Ethnicity:Caucasian

Comments:No virus particles.

Ultrastructural features include microvilli and desmosomes, glycogen granules, large lysosomes, bundles of cytoplasmic fibrils.

The SK-BR-3 cell line overexpresses the HER2/c-erb-2 gene product. [30816]



Propagation:ATCC complete growth medium: The base medium for this cell line is ATCC-formulated McCoy's 5a Medium Modified, Catalog No. 30-2007. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.

Atmosphere: air, 95%; carbon dioxide (CO2), 5%

Temperature: 37.0°C



Subculturing:Protocol:
  1. Remove and discard culture medium.

    • Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.


    • Add appropriate aliquots of the cell suspension to new culture vessels.

    • Incubate cultures at 37°C.

    • Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

    • Briefly rinse the cell layer with 0.25% (w/v) Trypsin, 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.

HTB-30
Subc*tion Ratio: A subc*tion ratio of 1:2 is recommended

Medium Renewal: 2 to 3 times per week



Preservation:Freeze medium: Complete growth medium, 95%; DMSO, 5%

Storage temperature: liquid nitrogen vapor temperature



Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2007

recommended serum:ATCC 30-2020

purified DNA:ATCC 45520

purified DNA:ATCC 45521

derived from same individual:ATCC CRL-2351

purified DNA:ATCC HTB-30D



References:21869: . Human tumor cells in vitro. New York: Plenum Press; 1975.
22468: Trempe GL. Human breast cancer in culture. Recent Results Cancer Res. 57: 33-41, 1976. PubMed: 1013510
22536: Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871
22539: Fogh J, et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59: 221-226, 1977. PubMed: 327080
23226: Pollack MS, et al. HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines. J. Natl. Cancer Inst. 66: 1003-1012, 1981. PubMed: 7017212
30816: Hudziak RM, et al. Monoclonal antibodies directed to the Her2 receptor. US Patent 5,677,171 dated Oct 14 1997
32275: Littlewood-Evans AJ, et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386-5390, 1997. PubMed: 9393764
32567: Chavany C, et al. p185erbB2 binds to GRP94 in vivo. J. Biol. Chem. 271: 4974-4977, 1996. PubMed: 8617772


















產(chǎn)品咨詢(xún)

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7
聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號(hào)7層

咨詢(xún)熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢(xún)
  • 掃一掃 微信咨詢(xún)

Copyright©2024 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
<object id="q8oyw"></object>
<sup id="q8oyw"><option id="q8oyw"></option></sup><object id="q8oyw"><tr id="q8oyw"></tr></object>
<center id="q8oyw"><center id="q8oyw"></center></center>
<object id="q8oyw"></object>
<acronym id="q8oyw"><div id="q8oyw"></div></acronym>
<object id="q8oyw"></object>
<acronym id="q8oyw"><wbr id="q8oyw"></wbr></acronym>
<object id="q8oyw"></object>
西畴县| 桓台县| 四会市| 当雄县| 本溪市| 若尔盖县| 岳普湖县| 辽阳县| 阿合奇县| 仪征市| 苏州市| 甘南县| 阿拉尔市| 泽普县| 渑池县| 辉南县| 墨竹工卡县| 炎陵县| 安庆市| 迁安市| 武平县| 三河市| 沈阳市| 宁蒗| 囊谦县| 眉山市| 南川市| 开鲁县| 平潭县| 察雅县| 清新县| 马鞍山市| 文水县| 库尔勒市| 白沙| 罗定市| 应用必备| 京山县| 鹤壁市| 柯坪县| 定边县| http://444 http://444 http://444 http://444 http://444 http://444